T. Andrew Crockett
2020
In 2020, T. Andrew Crockett earned a total compensation of $1.7M as Chief Executive Officer at Carbylan Therapeutics, a 47% decrease compared to previous year.
Compensation breakdown
| Option Awards | $1,163,160 |
|---|---|
| Salary | $556,120 |
| Other | $11,882 |
| Total | $1,731,162 |
Crockett received $1.2M in option awards, accounting for 67% of the total pay in 2020.
Crockett also received $556.1K in salary and $11.9K in other compensation.
Rankings
In 2020, T. Andrew Crockett's compensation ranked 6,201st out of 13,090 executives tracked by ExecPay. In other words, Crockett earned more than 52.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,201 out of 13,090 | 53rd |
Division Manufacturing | 2,561 out of 5,620 | 54th |
Major group Chemicals And Allied Products | 1,032 out of 2,253 | 54th |
Industry group Drugs | 891 out of 1,953 | 54th |
Industry Pharmaceutical Preparations | 665 out of 1,458 | 54th |
Source: SEC filing on August 25, 2020.
Crockett's colleagues
We found two more compensation records of executives who worked with T. Andrew Crockett at Carbylan Therapeutics in 2020.